Sumita Ray - 25 Jan 2022 Form 4 Insider Report for Calithera Biosciences, Inc.

Reporting relationship: SVP, GENERAL COUNSEL & CHIEF COMPLIANCE OFFICER
Issuer ticker: N/A
Reported as of: 25 Jan 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Jan 2022, 15:17:03 UTC
Prior SEC filing: 09 Nov 2021
Next SEC filing: 07 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Sumita Ray

Key filing fact

Sumita Ray filed Form 4 for Calithera Biosciences, Inc. on 27 Jan 2022.

Key facts

This page summarizes Sumita Ray's Form 4 filing for Calithera Biosciences, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 27 Jan 2022, 15:17.

Change

Previous filing in this sequence was filed on 09 Nov 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CALA transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +165,000
Change %
Price: $0.000000
Shares after: 165,000
Date: 25 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 165,000
Exercise price: $0.4400
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

One-fourth (1/4th) of the Option vests one year after January 25, 2022; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.

SEC remarks

SVP, GENERAL COUNSEL & CHIEF COMPLIANCE OFFICER